Screener
Cytosorbents CTSO Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$9.6MBeat by $248.0K
EPS-$0.07Miss by $0.03
Revenue estimate$9.4M
EPS estimate-$0.04
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$9.9M
EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Cytosorbents report Q2 2026 earnings?
- Cytosorbents (CTSO) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Cytosorbents's Q2 2026 revenue and EPS?
- Cytosorbents reported revenue of $9.6M and eps of $-0.07 for Q2 2026.
- Did Cytosorbents beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $9.4M by $248.0K. EPS missed the consensus estimate of $-0.04 by $0.03.
- How did Cytosorbents's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 0.2% from $9.6M a year earlier and eps declined 40.0% from $-0.05.
- Where can I find Cytosorbents's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-092039) and the 10-Q periodic report (0001104659-26-092006) directly on SEC EDGAR. The filing index links above go to sec.gov.
